PlainBillCongress, translated.Legislation. Context. Public interest.Read twice and referred to the Committee on Finance.
Congressional Research Service
Version 00 · Introduced in Senate · Mar 2, 2011
Strengthening Program Integrity and Accountability in Health Care Act of 2011 - Amends title XVIII (Medicare) of the Social Security Act (SSA) to: (1) change from discretionary to mandatory the authority of the Secretary of Health and Human Services (HHS) to suspend Medicare and Medicaid payments pending investigation of credible allegations of fraud; and (2) require the Secretary to extend to up to 365 calendar days for particular categories of service providers or suppliers in which fraud, waste, or abuse is likely the number of days in which Medicare claims are required to be paid in order to ensure that they are clean claims.
Requires the Inspector General of HHS to notify the relevant congressional committees within 30 days after transmitting to another HHS agency a management implication report (which details investigative findings about the possible implication of agency management in prohibited or otherwise inappropriate transactions).
Directs the Secretary, acting through the Administrator of the Centers for Medicare & Medicaid Services, to establish an information sharing program regarding beneficiary medical ID theft under the programs under SSA titles XVIII (Medicare), XIX (Medicaid), and XXI (State Children's Health Insurance) (CHIP).
Showing the opening paragraphs of the official summary.
Amends SSA title XI to authorize the Secretary to exclude from federal health care programs entities affiliated with a sanctioned entity, as well as any officer or managing employee of an affiliated entity (currently, only individuals with an ownership or control interest in a sanctioned entity), if the affiliated entity was so affiliated at the time of any of the conduct forming the basis for the conviction or exclusion of the sanctioned entity.
Directs the Secretary to make available to the public Medicare claims and payment data.
Amends SSA title XIX to require a state Medicaid agency to exclude from program participation with respect to a particular period any individual or entity which owns, controls, or manages an entity that: (1) has delinquent unpaid overpayments during such period; (2) is suspended or excluded from Medicaid participation or whose participation is terminated; or (3) is affiliated with an individual or entity that has been suspended or excluded from Medicaid participation or whose participation is terminated.
Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary to list on the Food and Drug Administration (FDA) Internet website certain new drugs (for human consumption) or new animal drugs that have not been approved by the FDA, together with the name of the person who listed such drug and the authority under such Act that does not require such drug to be subject to FDA approval.
Amends SSA title XIX to prohibit a state from making a Medicaid payment for a covered outpatient drug which has not been FDA-approved.
Amends SSA title XI to require individuals or entities that participate in or conduct activities under federal health care programs to comply with certain congressional requests for documents, information, or interviews.
People & committees
Sen. Grassley, Chuck [R-IA] · R–IA
Legislative record
A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.
Read twice and referred to the Committee on Finance.
Sponsor introductory remarks on measure. (CR S1140-1141)
Introduced in Senate
Primary sources
Text links open the official source. We currently store references to these documents.
No related bills are listed in this snapshot. This does not establish whether the proposal has appeared in earlier Congresses.
Source last updated: Aug 14, 2025. Consult Congress.gov for the current record.
AI Conversation Starters
Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.
Analyze S.454 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.
Examine S.454 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.
Examine S.454 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.
Examine S.454 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.